Share this story

Peter Dunlap-Shohl drew editorial cartoons for the Anchorage Daily News for 25 years. He was diagnosed with Parkinson’s disease in 2002. Since diagnosis he maintains two Parkinson’s blogs, ‘Frozen Grin’ and ‘Off and On, The Alaska Parkinson’s Rag’, and published his first graphic novel ‘My Degeneration’ with Penn State University in 2015.

A natural educator, Dunlap-Shohl is a great explainer of complex medical concepts and vocabulary

Michael J Green and MK Czerwiec

Medical experts praise Parkinson’s graphic novel

Perspectives

Author: Almaz OhenePublished: 26 January 2017

Prep: Cook: Serves:

Graphic novel ‘My Degeneration: A Journey Through Parkinson’s’ by Peter Dunlap-Shohl has been recognised by The Journal of the American Medical Association (JAMA) as “one of the best graphic medicine books of 2016”

The world-renowned Journal of the American Medical Association (JAMA) has praised political cartoonist-turned graphic novelist Peter Dunlap-Shohl for his contribution to the burgeoning ‘graphic medicine’ patient information movement.

The article applauds Dunlap-Shohl for the portrayal of his Parkinson’s diagnosis and subsequent acceptance of the condition. The paper’s authors, Michael J Green and MK Czerwiec, say that the book “is a masterclass in communication that should be read by students and practitioners alike, showcasing the strength of comics at both telling and showing.”

In an early section of the book, Dunlap-Shohl reports on some of the thoughtless and harsh things said by medical professionals. One of the doctors says: “It’s Parkinson’s. But at your age, something else will pick you off before it’s a major problem.”

Instead of becoming defeatist, Dunlap-Shohl’s character takes the situation a step further by offering his own tips and positive spin on how a doctor should deliver a Parkinson’s diagnosis.

‘Try this. “You have Parkinson’s disease. A few decades ago, this would have meant a drastically shortened life span and much suffering… We’ve got tools now to manage the disease effectively for years, for decades even. And more coming.”’

A later chapter offers the reader a new perspective about how the “mask of Parkinson’s” – when facial muscles become immobilised forcing a blank expression – can leave patients open to accidental misinterpretation. When Dunlap-Shohl’s character is happy, his face can’t form the matching emotional expression, and his words come across as “angry, sarcastic, or something altogether different,” according to Green and Czerwiec. “Interestingly, the medium of comics can remedy this miscommunication, since comics convey words and images, providing the visual cues that propel a story along with its intended emotional tone. It’s a brilliant way to make both points.”

After we reached out to Peter to tell him his work had been highly praised in JAMA, he said: “It was a pleasant shock. Comics have been trivialised for as long as they have been around, so it’s a thrill to see them taken seriously. It’s also a challenge to continue to do meaningful work without losing our raffish, outsider charm.”

The authors of the article added: “As clinicians, we particularly appreciated the generosity of his ample advice – which ranges from helpful tips about exercise to how to walk when stuck (try going backwards).”

Peter doesn’t let his Parkinson’s hold back his creativity and he is currently working on a big piece of comic strip work on Alaska’s nuclear weapons history.

The full journal article, ‘Graphic Medicine: The Best of 2016’, can be found on ‘The Journal of the American Medical Association’ website.

Share this story

Peter Dunlap-Shohl drew editorial cartoons for the Anchorage Daily News for 25 years. He was diagnosed with Parkinson’s disease in 2002. Since diagnosis he maintains two Parkinson’s blogs, ‘Frozen Grin’ and ‘Off and On, The Alaska Parkinson’s Rag’, and published his first graphic novel ‘My Degeneration’ with Penn State University in 2015.

A natural educator, Dunlap-Shohl is a great explainer of complex medical concepts and vocabulary

Michael J Green and MK Czerwiec

Share this story

Comments

http://www.ganglbauer.info Gerald Ganglbauer

There’s only one good thing about Parkinson’s: The constant fight against this damn disease brings our real potential to the surface. Many of us have developed skills they didn’t know they had before, launched projects they didn’t dream of before, and work much harder and more creative than before. Like our life depends on it. And, yes, it does.

IN THE NEWS

Carefully selected news stories from the international Parkinson's community.

3 weeks ago

Excess calcium in brain could cause Parkinson’s

Researchers at the University of Cambridge, UK, have discovered that excess levels of calcium in brain cells may lead to the formation of the toxic clusters that signify Parkinson’s disease. The findings, reported in the journal ‘Nature Communications’, show that calcium can influence the interaction between small membranous structures inside nerve endings, which are important for neuronal signaling in the brain, and alpha-synuclein – the protein associated with Parkinson’s disease. Dr Janin Lautenschläger, the paper’s first author, said: “This is the first time we’ve seen that calcium influences the way alpha-synuclein interacts with synaptic vesicles. We think that alpha-synuclein is almost like a calcium sensor. In the presence of calcium, it changes its structure and how it interacts with its environment, which is likely very important for its normal function.”

Jewish people with Crohn’s disease more likely to carry LRRK2 gene mutation

A scientific study has concluded that there may be a link between Parkinson’s and Crohn’s disease within the Ashkenazi Jewish community. The study’s findings, which were published in the journal ‘Science Translational Medicine’, has found that members of the population with Crohn’s disease are more likely to carry the LRRK2 mutation which is a significant cause of Parkinson’s. Lead researcher Dr Inga Peter, professor of genetics and genomic sciences at the Icahn School of Medicine, New York, US, said: “Crohn’s disease is a complex disorder with multiple genes and environmental factors involved, which disproportionately affects individuals of Ashkenazi Jewish ancestry. “The presence of shared LRRK2 mutations in patients with Crohn’s disease and Parkinson’s disease provides refined insight into disease mechanisms and may have major implications for the treatment of these two seemingly unrelated diseases.”

Could caffeine in the blood help diagnose Parkinson’s?

Blood caffeine levels could be promising diagnostic biomarkers for early-stage Parkinson’s, Japanese researchers reported in the journal ‘Neurology’ earlier this month. The study found that people with Parkinson’s had lower levels of caffeine and caffeine metabolites in their blood than people without the disease, at the same consumption rate. Caffeine concentrations also were decreased in Parkinson’s patients with motor fluctuations than in those without Parkinson’s. However, patients in more severe disease stages did not have lower caffeine levels. The study’s authors, Dr David Munoz, University of Toronto, and Dr Shinsuke Fujioka, Fukuoka University, suggested that the “decrease in caffeine metabolites occurs from the earliest stages of Parkinson’s.” They added: “If a future study were to demonstrate similar decreases in caffeine in untreated patients with Parkinson’s […] the implications of the current study would take enormous importance.”